Other
Estimated litigation liability
AbbVie Estimated litigation liability increased by 6.3% to $1.70B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 5.6%, from $1.80B to $1.70B. Over 2 years (FY 2023 to FY 2025), Estimated litigation liability shows a downward trend with a -10.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ4 2023
Last reportedQ1 2026May 8, 2026
Metric ID:
other_litigation_reserveHistorical Data
8 periods
| Q4 '23 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|
| Value | $2.00B | $2.40B | $2.50B | $1.80B | $1.80B | $1.50B | $1.60B | $1.70B |
| QoQ Change | — | +20.0% | +4.2% | -28.0% | +0.0% | -16.7% | +6.7% | +6.3% |
| YoY Change | — | — | +25.0% | — | — | -37.5% | -36.0% | -5.6% |
Range$1.50B – $2.50B
CAGR-8.9%
Avg YoY Growth-13.5%
Median YoY Growth-20.8%
Current Streak2 quarters growth
Estimated litigation liability at Other Companies
Frequently Asked Questions
- What is AbbVie's estimated litigation liability?
- AbbVie (ABBV) reported estimated litigation liability of $1.70B in Q1 2026.
- How has AbbVie's estimated litigation liability changed year-over-year?
- AbbVie's estimated litigation liability decreased by 5.6% year-over-year, from $1.80B to $1.70B.
- What is the long-term trend for AbbVie's estimated litigation liability?
- Over 2 years (2023 to 2025), AbbVie's estimated litigation liability has grown at a -10.6% compound annual growth rate (CAGR), from $2.00B to $1.60B.